SLC30A8 polymorphism and type 2 diabetes risk: Evidence from 27 study groups

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 6, 2011, Pages 398-405

  Jing, Y L ^a   Sun, Q M ^a   Bi, Y ^b   Shen, S M ^b   Zhu, D L ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Meta analysis; SLC30A8 (rs13266634) polymorphism; Type 2 diabetes

Indexed keywords

CATION TRANSPORT PROTEIN; SLC30A8 PROTEIN, HUMAN;

ARTICLE; ASIAN; BIOLOGICAL MODEL; CASE CONTROL STUDY; CAUCASIAN; CONFIDENCE INTERVAL; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; META ANALYSIS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MODELS, GENETIC; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 79955957666     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.11.004     Document Type: Article

References (45)

1. Permutt M.A., Wasson J., Cox N. Genetic epidemiology of diabetes. J Clin Invest 2005, 115:1431-1439.
2. Perry J.R., Frayling T.M. New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function. Curr Opin Clin Nutr Metab Care 2008, 11:371-377.
3. Boesgaard T.W., Zilinskaite J., Vänttinen M., Laakso M., Jansson P.A., Hammarstedt A., et al. The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients - the EUGENE2 study. Diabetologia 2008, 51:816-820.
4. Staiger H., Machicao F., Stefan N., Tschritter O., Thamer C., Kantartzis K., et al. Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function. PLoS One 2007, 2. e832.
5. Kirchhoff K., Machicao F., Haupt A., Schäfer S.A., Tschritter O., Staiger H., et al. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 2008, 51:597-601.
6. Mocchegiani E., Giacconi R., Malavolta M. Zinc signalling and subcellular distribution: emerging targets in type 2 diabetes. Trends Mol Med 2008, 14:419-428.
7. Chimienti F., Favier A., Seve M. ZnT-8, a pancreatic beta-cell-specific zinc transporter. Biometals 2005, 18:313-317.
8. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
9. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345.
10. Saxena R., Voight B.F., Lyssenko V., Burtt N.P., de Bakker P.I., Chen H., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316:1331-1336.
11. Zeggini E., Weedon M.N., Lindgren C.M., Frayling T.M., Elliott K.S., Lango H., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316:1336-1341.
12. Horikoshi M., Hara K., Ito C., Shojima N., Nagai R., Ueki K., et al. Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia 2007, 50:2461-2466.
13. Steinthorsdottir V., Thorleifsson G., Reynisdottir I., Benediktsson R., Jonsdottir T., Walters G.B., et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007, 39:770-775.
14. Hertel J.K., Johansson S., Raeder H., Midthjell K., Lyssenko V., Groop L., et al. Genetic analysis of recently identified type 2 diabetes loci in 1638 unselected patients with type 2 diabetes and 1858 control participants from a Norwegian population-based cohort (the HUNT study). Diabetologia 2008, 51:971-977.
15. Lee Y.H., Kang E.S., Kim S.H., Han S.J., Kim C.H., Kim H.J., et al. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J Hum Genet 2008, 53:991-998.
16. Sanghera D.K., Ortega L., Han S., Singh J., Ralhan S.K., Wander G.S., et al. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet 2008, 9:59.
17. Ng M.C., Park K.S., Oh B., Tam C.H., Cho Y.M., Shin H.D., et al. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6719 Asians. Diabetes 2008, 57:2226-2233.
18. Furukawa Y., Shimada T., Furuta H., Matsuno S., Kusuyama A., Doi A., et al. Polymorphisms in the IDE-KIF11-HHEX gene locus are reproducibly associated with type 2 diabetes in a Japanese population. J Clin Endocrinol Metab 2008, 93:310-314.
19. Cauchi S., Meyre D., Durand E., Proença C., Marre M., Hadjadj S., et al. Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS One 2008, 3. e2031.
20. Horikawa Y., Miyake K., Yasuda K., Enya M., Hirota Y., Yamagata K., et al. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab 2008, 93:3136-3141.
21. Lewis J.P., Palmer N.D., Hicks P.J., Sale M.M., Langefeld C.D., Freedman B.I., et al. Association analysis in African Americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies. Diabetes 2008, 57:2220-2225.
22. Cauchi S., Nead K.T., Choquet H., Horber F., Potoczna N., Balkau B., et al. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Med Genet 2008, 9:45.
23. Wu Y., Li H., Loos R.J., Yu Z., Ye X., Chen L., et al. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes 2008, 57:2834-2842.
24. Xiang J., Li X.Y., Xu M., Hong J., Huang Y., Tan J.R., et al. Zinc transporter-8 gene (SLC30A8) is associated with type 2 diabetes in Chinese. J Clin Endocrinol Metab 2008, 93:4107-4112.
25. Omori S., Tanaka Y., Takahashi A., Hirose H., Kashiwagi A., Kaku K., et al. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes 2008, 57:791-795.
26. Rong R., Hanson R.L., Ortiz D., Wiedrich C., Kobes S., Knowler W.C., et al. Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes 2009, 58:478-488.
27. Tabara Y., Osawa H., Kawamoto R., Onuma H., Shimizu I., Miki T., et al. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes 2009, 58:493-498.
28. van Hoek M., Dehghan A., Witteman J.C., van Duijn C.M., Uitterlinden A.G., Oostra B.A., et al. Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes 2008, 57:3122-3128.
29. Lyssenko V., Jonsson A., Almgren P., Pulizzi N., Isomaa B., Tuomi T., et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008, 359:2220-2232.
30. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
31. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
32. Petitti D. Meta-analysis, decision analysis, and cost-effectiveness analysis 1994, Oxford University Press, New York.
33. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
34. Gohlke H., Ferrari U., Koczwara K., Bonifacio E., Illig T., Ziegler A.G. SLC30A8 (ZnT8) Polymorphism is associated with young age at type 1 diabetes onset. Rev Diabet Stud 2008, 5:25-27.
35. Brorsson C., Bergholdt R., Sjögren M., Eising S., Sørensen K.M., Hougaard D.M., et al. A non-synonymous variant in SLC30A8 is not associated with type 1 diabetes in the Danish population. Mol Genet Metab 2008, 94:386-388.
36. Qu H.Q., Grant S.F., Bradfield J.P., Kim C., Frackelton E., Hakonarson H., et al. Association analysis of type 2 diabetes Loci in type 1 diabetes. Diabetes 2008, 57:1983-1986.
37. Cauchi S., Proença C., Choquet H., Gaget S., De Graeve F., Marre M., et al. Analysis of novel risk loci for type 2 diabetes in a general French population: the D.E.S.I.R. study. J Mol Med 2008, 86:341-348.
38. Lin CY, Chen PC, Kuo HK, Lin LY, Lin JW, Hwang JJ. Effects of obesity, physical activity, and cardiorespiratory fitness on blood pressure, inflammation, and insulin resistance in the National Health and Nutrition Survey 1999-2002. Nutr Metab Cardiovasc Dis in press, doi:10.1016/j.numecd.2009.06.005.
39. Morini E., Prudente S., Succurro E., Chandalia M., Zhang Y.Y., Mammarella S., et al. IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of 'low-frequency-low-risk' variants. Diabetologia 2009, 52:1852-1857.
40. McAteer J.B., Prudente S., Bacci S., Lyon H.N., Hirschhorn J.N., Trischitta V., et al. The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42,042 subjects. Diabetes 2008, 57:1125-1130.
41. Rossi MC, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D, et al. Obesity and changes in urine albumin/creatinine ratio in patients with type 2 diabetes: the DEMAND Study. Nutr Metab Cardiovasc Dis in press, doi:10.1016/j.numecd.2009.02.013.
42. Palmer N.D., Goodarzi M.O., Langefeld C.D., Ziegler J., Norris J.M., Haffner S.M., et al. Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study. Diabetes 2008, 57:1093-1100.
43. Takeuchi F., Serizawa M., Yamamoto K., Fujisawa T., Nakashima E., Ohnaka K., et al. Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 2009, 58:1690-1699.
44. Nicolson T.J., Bellomo E.A., Wijesekara N., Loder M.K., Baldwin J.M., Gyulkhandanyan A.V., et al. Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 2009, 58:2070-2083.
45. Fu Y., Tian W., Pratt E.B., Dirling L.B., Shyng S.L., Meshul C.K., et al. Down-regulation of ZnT8 expression in INS-1 rat pancreatic beta cells reduces insulin content and glucose-inducible insulin secretion. PLoS One 2009, 4. e5679.